×

Moving towards a multi-specialty portfolio: Solvay CFO

1:25 AM ET Tue, 8 Nov 2016

Belgian chemicals firm Solvay has raised its guidance saying it expects double-digit EBITDA growth for the fourth quarter of 2016. Its CFO, Karim Hajjar discusses.